Exscientia is a global pharmatech company using patient-first artificial intelligence (AI) to discover better drugs, faster. Their validated platform has delivered the first three AI-designed drugs to enter clinical trials and significantly accelerated pre-clinical drug discovery with a 10x productivity improvement compared to industry standards.
